Fallowfield Lesley, Matthews Lucy, Francis Adele, Jenkins Valerie, Rea Daniel
Sussex Health Outcomes Research and Education in Cancer (SHORE-C), Brighton & Sussex Medical School, University of Sussex, Falmer, Brighton BN1 9QG, UK.
Sussex Health Outcomes Research and Education in Cancer (SHORE-C), Brighton & Sussex Medical School, University of Sussex, Falmer, Brighton BN1 9QG, UK.
Breast. 2014 Oct;23(5):693-6. doi: 10.1016/j.breast.2014.06.013. Epub 2014 Jun 27.
In the absence of definitive data about the natural history of DCIS the appropriateness of describing DCIS as cancer is controversial.
We conducted a survey amongst British Breast Group (BBG) members, to determine which descriptions of DCIS were deemed most accurate and appropriate.
54/73 (74%) attendees completed the survey: A majority (34/54; 63%) said they would be comfortable using the description that explained DCIS as abnormal cells in the milk ducts that had not spread into other breast tissue and which did not need urgent treatment as if it was breast cancer and this description was overall the most preferred (24/54; 44%).
Little consensus exists regarding how best to explain low grade DCIS to patients.
由于缺乏关于导管原位癌（DCIS）自然史的确切数据，将DCIS描述为癌症是否恰当存在争议。
我们对英国乳腺组（BBG）成员进行了一项调查，以确定哪种DCIS描述被认为最准确和恰当。
73名参与者中有54名（74%）完成了调查：大多数人（34/54；63%）表示，他们会乐意使用将DCIS解释为乳腺导管内未扩散到其他乳腺组织且不需要像乳腺癌那样紧急治疗的异常细胞的描述，并且该描述总体上是最受欢迎的（24/54；44%）。
在如何最好地向患者解释低级别DCIS方面，几乎没有达成共识。
